Back to search

Article

Cholesteryl Ester Transfer Protein as a Drug Target for Cardiovascular Disease

2020-09-09

Abstract excerpt

Drug development of cholesteryl ester transfer protein (CETP) inhibition to prevent coronary heart disease (CHD) has yet to deliver licensed medicines. To distinguish compound from drug target failure, we compared evidence from clinical trials and Mendelian randomization (MR) results. Findings from meta-analyses of CETP inhibitor trials (≥ 24 weeks follow-up) were used to judge between-compound heterogeneity in tr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3d4cde65-ca74-5bfc-94cc-fa2694dde4fc
DOI
10.1101/2020.09.07.20189571
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cholesteryl Ester Transfer Protein as a Drug Target for Cardiovascular DiseaseDOI 10.1101/2020.09.07.20189571
Select a neighboring publication to make it the new centre.